Skip to main content

Evercore ISI Sticks to Their Buy Rating for Omada Health, Inc. (OMDA)

Tipranks - Tipranks - Wed Nov 19, 2025

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Omada Health, Inc. yesterday and set a price target of $28.00. The company’s shares closed yesterday at $19.46.

TipRanks Black Friday Sale

According to TipRanks, Anderson CFA is an analyst with an average return of -2.4% and a 47.80% success rate. Anderson CFA covers the Healthcare sector, focusing on stocks such as Henry Schein, Align Tech, and Envista Holdings.

In addition to Evercore ISI, Omada Health, Inc. also received a Buy from Morgan Stanley’s Craig Hettenbach in a report issued yesterday. However, on November 8, TR | OpenAI – 4o reiterated a Hold rating on Omada Health, Inc. (NASDAQ: OMDA).

See Insiders’ Hot Stocks on TipRanks >>

Based on Omada Health, Inc.’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $68.03 million and a GAAP net loss of $3.18 million. In comparison, last year the company earned a revenue of $35.1 million and had a GAAP net loss of $18.97 million

Read More on OMDA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).